Package 42291-853-01

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 42291-853-01
Digits Only 4229185301
Product NDC 42291-853
Product ID 42291-853_4875cced-75af-ed7f-e063-6294a90addfa
Description

100 TABLET in 1 BOTTLE (42291-853-01)

Marketing

Marketing Status
Marketed Since 2020-04-13
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4875cced-75af-ed7f-e063-6294a90addfa", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897666", "897683", "897722"], "spl_set_id": ["a32f346e-71cf-cc11-e053-2a95a90ae88c"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (42291-853-01)", "package_ndc": "42291-853-01", "marketing_start_date": "20200413"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "42291-853_4875cced-75af-ed7f-e063-6294a90addfa", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "42291-853", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "40 mg/1"}], "application_number": "ANDA071881", "marketing_category": "ANDA", "marketing_start_date": "20200413", "listing_expiration_date": "20271231"}